Switch to:
More From Other Websites
Nasdaq stocks posting largest percentage increases Oct 21 2014
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results Oct 15 2014
ARIAD to Webcast Conference Call on Third Quarter 2014 Financial Results Oct 15 2014
ARIAD's Iclusig Gains Positive Recommendation from PRAC Oct 14 2014
ARIAD Announces Recommendation for Iclusig by the Pharmacovigilance Risk Assessment Committee of the... Oct 10 2014
EU agency backs continued use of Ariad leukaemia drug Oct 10 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Oct 10 2014
ARIAD Gets Breakthrough Therapy Designation for AP26113 Oct 06 2014
ARIAD and Bellicum Announce Revised License Agreement for ARIAD’s Cell-Signaling Technology Oct 06 2014
Wayfair rises, Westport Innovations cuts 2014 forecast Oct 05 2014
U.S. equities finish mixed Oct 02 2014
Free Fall Continues For Freddie Mac, Fannie Mae Oct 02 2014
Why Ariad Pharmaceuticals (ARIA) Stock Is Spiking Today Oct 02 2014
Ariad Pharma's lung cancer drug gets breakthrough therapy status Oct 02 2014
ARIAD’s AP26113 Receives FDA Breakthrough Therapy Designation For ALK+ Non-Small Cell Lung Cancer... Oct 02 2014
How one trader is betting on Ariad Sep 30 2014
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 29 2014
Cancer drug stocks on the move amid striking data Sep 29 2014
ARIAD Presents Updated Clinical Data on AP26113 in Patients with ALK+ Non-Small Cell Lung Cancer Sep 29 2014
Ariad Director Resignation May Mean CEO Berger One Step Closer to Exit Sep 19 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK